摘要
Purpose: The purpose was to explore the efficacy of a commercial smartwatch with a blood pressure-monitoring feature. Design: A randomized controlled trial. Methods: Sixty healthy young adults were recruited. Participants were randomly allocated to wear a commercial smartwatch, one with and one without a blood pressure-monitoring feature for 12 weeks. Data were collected using Omron HEM-907, Inbody 270S, and the International Physical Activity Questionnaire. Findings: Results revealed a significant effect and group-by-time interaction on diastolic blood pressure. After 12 weeks in participants who wore a smartwatch with a blood pressure-monitoring feature, the systolic and diastolic blood pressure and resting heart rate had decreased. Conclusion: Using commercial smartwatches with a blood pressure-monitoring feature is a feasible approach to support self-management, increase awareness, and promote physical activity for health promotion, obesity and chronic disease prevention. Clinical relevance: Wearable technologies may be an innovative strategy for preventing high blood pressure by continuous self-monitoring and healthy behavior modifications.
原文 | 英語 |
---|---|
頁(從 - 到) | 324-331 |
頁數 | 8 |
期刊 | Journal of Nursing Scholarship |
卷 | 54 |
發行號 | 3 |
DOIs | |
出版狀態 | 接受/付印 - 2021 |
ASJC Scopus subject areas
- 護理(全部)